Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

The Association of Tacrolimus Formulation Switching with Trough Concentration Variability: A Retrospective Cohort Study of Tacrolimus Use Post-Kidney Transplantation Based on National Drug Code (NDC) Numbers.

Schwartz JJ, Lee E, Butler AP, Facklam DP, Franks B, Spalding JR, Vassilakis ME, Thal GD, Irish WD.

Adv Ther. 2019 Jun;36(6):1358-1369. doi: 10.1007/s12325-019-00950-5. Epub 2019 Apr 19.

PMID:
31004326
2.

Micafungin alone or in combination with other systemic antifungal therapies in hematopoietic stem cell transplant recipients with invasive aspergillosis.

Kontoyiannis DP, Ratanatharathorn V, Young JA, Raymond J, Laverdière M, Denning DW, Patterson TF, Facklam D, Kovanda L, Arnold L, Lau W, Buell D, Marr KA.

Transpl Infect Dis. 2009 Feb;11(1):89-93. doi: 10.1111/j.1399-3062.2008.00349.x. Epub 2008 Oct 8.

PMID:
18983417
3.

Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosis.

Denning DW, Marr KA, Lau WM, Facklam DP, Ratanatharathorn V, Becker C, Ullmann AJ, Seibel NL, Flynn PM, van Burik JA, Buell DN, Patterson TF.

J Infect. 2006 Nov;53(5):337-49. Epub 2006 May 6.

PMID:
16678903
4.

International, open-label, noncomparative, clinical trial of micafungin alone and in combination for treatment of newly diagnosed and refractory candidemia.

Ostrosky-Zeichner L, Kontoyiannis D, Raffalli J, Mullane KM, Vazquez J, Anaissie EJ, Lipton J, Jacobs P, van Rensburg JH, Rex JH, Lau W, Facklam D, Buell DN.

Eur J Clin Microbiol Infect Dis. 2005 Oct;24(10):654-61. Erratum in: Eur J Clin Microbiol Infect Dis. 2006 Jan;25(1):69.

PMID:
16261306
5.

Safety, tolerability, and pharmacokinetics of Micafungin (FK463) in febrile neutropenic pediatric patients.

Seibel NL, Schwartz C, Arrieta A, Flynn P, Shad A, Albano E, Keirns J, Lau WM, Facklam DP, Buell DN, Walsh TJ.

Antimicrob Agents Chemother. 2005 Aug;49(8):3317-24.

7.

Successful treatment of oesophageal candidiasis by micafungin: a novel systemic antifungal agent.

Pettengell K, Mynhardt J, Kluyts T, Lau W, Facklam D, Buell D; FK463 South African Study Group.

Aliment Pharmacol Ther. 2004 Aug 15;20(4):475-81.

8.

Coadministration of tacrolimus and mycophenolate mofetil in stable kidney transplant patients: pharmacokinetics and tolerability.

Pirsch J, Bekersky I, Vincenti F, Boswell G, Woodle ES, Alak A, Kruelle M, Fass N, Facklam D, Mekki Q.

J Clin Pharmacol. 2000 May;40(5):527-32.

PMID:
10806606
9.

Meta-analysis of FK 506 and mycophenolate mofetil refractory rejection trials in renal transplantation. Refractory Rejection Meta-Analysis Study Group.

Woodle ES, Jordan ML, Facklam D, Shapiro R, Danovitch GM.

Transplant Proc. 1998 Jun;30(4):1297-8. No abstract available.

PMID:
9636526
10.

Cohort maintenance and comparability in a pharmacoepidemiologic study using a commercial consumer panel to recruit comparators.

Gardner JS, Szpunar CA, O'Connell MJ, Facklam DP, Mariano JP, Borden EK, Leinweber FB.

Pharmacoepidemiol Drug Saf. 1996 Jul;5(4):207-14.

PMID:
15073822
11.

Use of a commercial consumer panel to recruit a comparator cohort for a pharmacoepidemiologic study.

Gardner JS, Szpunar CA, O'Connell MJ, Facklam DP, Mariano JP, Borden EK, Leinweber FB.

Pharmacoepidemiol Drug Saf. 1996 May;5(3):165-72.

PMID:
15073833
12.

Weight gain and lipid profile changes in liver transplant recipients: long-term results of the American FK506 Multicenter Study.

Mor E, Facklam D, Hasse J, Sheiner P, Emre S, Schwartz M, Miller C.

Transplant Proc. 1995 Feb;27(1):1126. No abstract available.

PMID:
7533363
13.

FK 506 in liver transplantation: correlation of whole blood levels with efficacy and toxicity. The US Multicenter FK 506 Dose Optimization.

Schwartz M, Holst B, Facklam D, Buell D.

Transplant Proc. 1995 Feb;27(1):1107. No abstract available.

PMID:
7533355
14.

Therapy with recombinant human erythropoietin in patients with myelodysplastic syndromes.

Stone RM, Bernstein SH, Demetri G, Facklam DP, Arthur K, Andersen J, Aster JC, Kufe D.

Leuk Res. 1994 Oct;18(10):769-76.

PMID:
7934135
15.

An epidemiologic postmarketing surveillance study of prescription acne medications.

Facklam DP, Gardner JS, Neidert GL, Westland MM.

Am J Public Health. 1990 Jan;80(1):50-3.

16.

Is post-marketing drug surveillance possible in the family practice setting? A collaborative study.

Facklam DP, Baker MI, Gardner JS, Herbert C, Grava-Gubins I.

Can Fam Physician. 1988 Apr;34:819-22.

Supplemental Content

Loading ...
Support Center